Optiver Holding
FHTX icon

Optiver Holding’s Foghorn Therapeutics FHTX Stock Holding History

Optiver Holding’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29 Sell
6
-288
-98% -$1.28K ﹤0.01% 2692
2026
Q1 		$1.41K Sell
294
-16
-5% -$88 ﹤0.01% 1981
2025
Q4 		$1.67K Hold
310
– – ﹤0.01% 2094
2025
Q3 		$1.52K Buy
+310
New +$1.64K ﹤0.01% 2451

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Optiver Holding's FHTX Position: Q2 2026 in Review

Optiver Holding reduced its Foghorn Therapeutics (FHTX) stake by 98% in Q2 2026, selling an estimated $1.28K and leaving 6 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Optiver Holding first reported a position in FHTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.67K in Q4 2025. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Optiver Holding held 6 shares of Foghorn Therapeutics worth $29 as of Q2 2026.
  • Optiver Holding sold 288 Foghorn Therapeutics shares in Q2 2026, an estimated $1.28K.
  • Foghorn Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2692 holding.
  • Optiver Holding first reported a position in Foghorn Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Foghorn Therapeutics position peaked at $1.67K in Q4 2025.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.